Research summary, original research, 2015

A New Design of a Lead-Acrylic Shield for Staff Dose Reduction in Radial and Femoral Access Coronary Catheterization

Eder H, Seidenbusch MC, Treitl M, Gilligan P. RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin. 2015

Read the original paper

In plain language

In a phantom study of coronary catheterization, adding a flexible lead curtain to the bottom of the ceiling shield cut ambient dose at the operator position by up to about 88%, and up to 91% with patient drapes. Clinical confirmation was pending.

At a glance

Type of study
Original research, Phantom or simulation study
Who was studied
Phantom or simulation (no people), Interventional cardiologists, Mixed lab staff
Summary based on
the abstract

What it found

  • A flexible protective curtain attached to the bottom of the ceiling-suspended lead-acrylic shield, in contact with the patient, markedly reduced ambient dose rate at the operator position compared with the bare shield.

    Key figures: up to (87.5% ± 7.1)

  • Combining the flexible curtain with radioprotective patient drapes gave the largest reduction.

    Key figures: up to (90.8% ± 7)

  • Assisting personnel standing next to the operator had similar reductions.

  • An enlarged shield better protected the head region of tall operators.

  • Authors suggest the curtain may help protect unshielded body parts such as the head and eye lenses; clinical effect is still being evaluated.

Limits to keep in mind

Phantom and Monte Carlo study measuring ambient dose rather than personal dose in clinical practice; reductions are maximum ('up to') values and real-world effectiveness was not yet tested. Number of scenarios and country not reported in the abstract.

How this summary was made

ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.